C. Demougeot et al., N-Acetylaspartate, a marker of both cellular dysfunction and neuronal loss: its relevance to studies of acute brain injury, J NEUROCHEM, 77(2), 2001, pp. 408-415
To evaluate the contribution of cellular dysfunction and neuronal loss to b
rain N-acetylaspartate (NAA) depletion, NAA was measured in brain tissue by
HPLC and UV detection in rats subjected to cerebral injury, associated or
not with cell death. When lesion was induced by intracarotid injection of m
icrospheres, the fall in NAA was related to the degree of embolization and
to the severity of brain oedema. When striatal lesion was induced by local
injection of malonate, the larger the lesion volume, the higher the NAA dep
letion. However, reduction of brain oedema and striatal lesion by treatment
with the lipophilic iron chelator dipyridyl (20 mg/kg, 1 h before and ever
y 8 h after embolization) and the inducible nitric oxide synthase inhibitor
aminoguanidine (100 mg/kg given 1 h before malonate and then every 9 h), r
espectively, failed to ameliorate the fall in NAA. Moreover, after systemic
administration of 3-nitropropionic acid, a marked reversible fall in NAA s
triatal content was observed despite the lack of tissue necrosis. Overall r
esults show that cellular dysfunction can cause higher reductions in NAA le
vel than neuronal loss, thus making of NAA quantification a potential tool
for visualizing the penumbra area in stroke patients.